These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 28129003)
1. Beyond platinum treatment for NSCLC: what does the future hold? Santarpia M; Karachaliou N; Rosell R Expert Rev Anticancer Ther; 2017 Apr; 17(4):293-295. PubMed ID: 28129003 [No Abstract] [Full Text] [Related]
2. Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cycles. Rossi A; Di Maio M Expert Rev Anticancer Ther; 2016 Jun; 16(6):653-60. PubMed ID: 27010977 [TBL] [Abstract][Full Text] [Related]
3. Best practice in the treatment of advanced squamous cell lung cancer. Ang YL; Tan HL; Soo RA Ther Adv Respir Dis; 2015 Oct; 9(5):224-35. PubMed ID: 25902866 [TBL] [Abstract][Full Text] [Related]
4. The safety of nivolumab for the treatment of advanced non-small cell lung cancer. Metro G; Ricciuti B; Brambilla M; Baglivo S; Soli I; Minenza E; Leonardi GC; D'arpino A; Colabrese D; Tazza M; Zicari D; Minotti V; Chiari R Expert Opin Drug Saf; 2017 Jan; 16(1):101-109. PubMed ID: 27910704 [TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of targeted agents monotherapy in advanced NSCLC. Zhang Q; Wu YL Expert Rev Clin Pharmacol; 2016; 9(1):143-55. PubMed ID: 26558941 [TBL] [Abstract][Full Text] [Related]
6. The safety and efficacy of nivolumab in advanced (metastatic) non-small cell lung cancer. Tanvetyanon T; Creelan BC; Antonia SJ Expert Rev Anticancer Ther; 2016 Sep; 16(9):903-10. PubMed ID: 27488231 [TBL] [Abstract][Full Text] [Related]
7. [Management of side effects with platinum doublet chemotherapy used for treatment of non-small cell lung cancer]. Kudo K; Nakagawa K Nihon Rinsho; 2015 Feb; 73 Suppl 2():542-7. PubMed ID: 25831819 [No Abstract] [Full Text] [Related]
13. Pembrolizumab for the treatment of PD-L1 positive advanced or metastatic non-small cell lung cancer. Dang TO; Ogunniyi A; Barbee MS; Drilon A Expert Rev Anticancer Ther; 2016; 16(1):13-20. PubMed ID: 26588948 [TBL] [Abstract][Full Text] [Related]
14. Immune checkpoint inhibitors as first-line and salvage therapy for advanced non-small-cell lung cancer. Decatris MP; O'Byrne KJ Future Oncol; 2016 Aug; 12(15):1805-22. PubMed ID: 27267211 [TBL] [Abstract][Full Text] [Related]
15. FDA Approval Summary: Pembrolizumab for the Treatment of Patients With Metastatic Non-Small Cell Lung Cancer Whose Tumors Express Programmed Death-Ligand 1. Sul J; Blumenthal GM; Jiang X; He K; Keegan P; Pazdur R Oncologist; 2016 May; 21(5):643-50. PubMed ID: 27026676 [TBL] [Abstract][Full Text] [Related]
16. [Chemotherapy for advanced NSCLC: is platinum indispensable?]. Pujol JL Rev Pneumol Clin; 2004 Jun; 60 Spec no 2():2S16-9. PubMed ID: 15211227 [No Abstract] [Full Text] [Related]